Tag: COVID19
Could Amgen test Enbrel or other anti-TNF drugs against COVID-19? CEO...
As Amgen ramps up a clinical trial of its psoriasis drug Otezla in COVID-19, the company’s scientists may be seriously considering whether another of...
J&J scores Ebola vaccine approval in Europe. Can the platform win...
Johnson & Johnson has spent years building up its vaccine capabilities, and amid the coronavirus pandemic, its work in the field has taken on new...
‘They’re more hated than COVID-19′: Minnesota governor blasts PhRMA for insulin...
Amid Congressional gridlock on drug prices, some states have taken matters into their own hands. That’s the case in Minnesota, where activists and officials lauded the passing...
Novavax hires new manufacturing chief to take COVID-19, flu vaccine hopefuls...
With its COVID-19 vaccine hopeful cycling through clinical trials, shot maker Novavax is working to flesh out its executive team to help lead the...
AstraZeneca reaches supply deal with Brazilian government to produce millions of...
As COVID-19 continues to rampage across the globe, Brazil stands alongside the U.S. as the countries hardest hit with new infections and deaths. But...
AstraZeneca, Daiichi Sankyo working on Japanese supply deal for COVID-19 vaccine...
AstraZeneca has picked up manufacturing partners at a rapid clip with a goal to produce 2 billion doses per year of the University of...
Moderna aims for light-speed COVID-19 shot rollout with Catalent fill-finish deal
With the search for a COVID-19 vaccine in hyperdrive, drugmakers have signed a wave of massive manufacturing tie-ups to help secure capacity for a...
FiercePharmaPolitics—FDA could approve ‘at least one’ COVID-19 vaccine before election: analyst
About six months into the pandemic and about 130 days until the U.S. presidential election, COVID-19 vaccines are moving ahead at record speeds. Now, a...
Roche’s Actemra falls short in Italian study in early-stage COVID-19 pneumonia
Roche’s Actemra, one of several anti-inflammatory drugs in testing against coronavirus, didn’t help patients with early-stage COVID-19 pneumonia, an Italian study found, though it...
Vaccine heroes? COVID-19 pitfalls, pricing put pharma on the spot
Pharma is looking to reset its image with COVID-19 vaccines and treatments, but landmines loom—with pricing likely the biggest.
The halo from pharma’s rapid response...
